Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Purow

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Journal of Neuro-Oncology|January 24, 2024
Phase I study targeting newly diagnosed grade 4 astrocytoma with bispecific antibody armed T cells (EGFR BATs) in combination with radiation and temozolomideCamilo E Fadul, Archana Thakur, Jungeun Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2017
Combined CDK4/6 and mTOR Inhibition Is Synergistic against Glioblastoma via Multiple MechanismsInan Olmez, Breanna Brenneman, Aizhen Xiao, et al.
Journal of Neuro-Oncology|July 20, 2022
The landscape of brain tumor mimics in neuro-oncology practiceLalanthica V Yogendran, Tuba Kalelioglu, Joseph H Donahue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2013
Hepatocyte growth factor sensitizes brain tumors to c-MET kinase inhibitionYing Zhang, Kaitlyn E Farenholtz, Yanzhi Yang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 4, 2009
The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumorsBenjamin Kefas, Laurey Comeau, Desiree H Floyd, et al.
Neuro-Oncology Advances|October 13, 2022
A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningiomaPriya Kumthekar, Sean Aaron Grimm, Roxanne T Aleman, et al.
Neuro-Oncology|August 8, 2014
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningiomaThomas J Kaley, Patrick Wen, David Schiff, et al.
Neuro-Oncology|October 20, 2017
Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alphaInan Olmez, Shawn Love, Aizhen Xiao, et al.
Neoplasia (New York, N.Y.)|March 27, 2023
Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5Hye-Min Jeon, Young Taek Oh, Yong Jae Shin, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2024
Microenvironment T-Type calcium channels regulate neuronal and glial processes to promote glioblastoma growthCollin J Dube, Ying Zhang, Shekhar Saha, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Journal of Neuro-Oncology|January 24, 2024
Phase I study targeting newly diagnosed grade 4 astrocytoma with bispecific antibody armed T cells (EGFR BATs) in combination with radiation and temozolomideCamilo E Fadul, Archana Thakur, Jungeun Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2017
Combined CDK4/6 and mTOR Inhibition Is Synergistic against Glioblastoma via Multiple MechanismsInan Olmez, Breanna Brenneman, Aizhen Xiao, et al.
Journal of Neuro-Oncology|July 20, 2022
The landscape of brain tumor mimics in neuro-oncology practiceLalanthica V Yogendran, Tuba Kalelioglu, Joseph H Donahue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2013
Hepatocyte growth factor sensitizes brain tumors to c-MET kinase inhibitionYing Zhang, Kaitlyn E Farenholtz, Yanzhi Yang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 4, 2009
The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumorsBenjamin Kefas, Laurey Comeau, Desiree H Floyd, et al.
Neuro-Oncology Advances|October 13, 2022
A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningiomaPriya Kumthekar, Sean Aaron Grimm, Roxanne T Aleman, et al.
Neuro-Oncology|August 8, 2014
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningiomaThomas J Kaley, Patrick Wen, David Schiff, et al.
Neuro-Oncology|October 20, 2017
Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alphaInan Olmez, Shawn Love, Aizhen Xiao, et al.
Neoplasia (New York, N.Y.)|March 27, 2023
Dopamine receptor D2 regulates glioblastoma survival and death through MET and death receptor 4/5Hye-Min Jeon, Young Taek Oh, Yong Jae Shin, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2024
Microenvironment T-Type calcium channels regulate neuronal and glial processes to promote glioblastoma growthCollin J Dube, Ying Zhang, Shekhar Saha, et al.
Pageof 7